SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 123 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,407,701 | +17.8% | 1,267,748 | +69.9% | 0.00% | +33.3% |
| Q2 2023 | $15,621,838 | +50.7% | 746,385 | +52.1% | 0.00% | +50.0% |
| Q1 2023 | $10,365,126 | -7.1% | 490,773 | +12.0% | 0.00% | 0.0% |
| Q4 2022 | $11,153,284 | -18.3% | 438,243 | -22.9% | 0.00% | -33.3% |
| Q3 2022 | $13,651,000 | +29.9% | 568,081 | +4.0% | 0.00% | +50.0% |
| Q2 2022 | $10,510,000 | +48.1% | 546,239 | +33.8% | 0.00% | +100.0% |
| Q1 2022 | $7,095,000 | -10.9% | 408,263 | +12.3% | 0.00% | -50.0% |
| Q4 2021 | $7,960,000 | +30.1% | 363,661 | +13.6% | 0.00% | +100.0% |
| Q3 2021 | $6,117,000 | -66.9% | 320,108 | -70.3% | 0.00% | -75.0% |
| Q2 2021 | $18,488,000 | +46.7% | 1,076,768 | +91.1% | 0.00% | +33.3% |
| Q1 2021 | $12,602,000 | +2.2% | 563,605 | +1.7% | 0.00% | 0.0% |
| Q4 2020 | $12,330,000 | +231.5% | 554,434 | +120.0% | 0.00% | +200.0% |
| Q3 2020 | $3,720,000 | -42.6% | 251,970 | -42.4% | 0.00% | -50.0% |
| Q2 2020 | $6,483,000 | +3669.2% | 437,462 | +2688.3% | 0.00% | – |
| Q1 2020 | $172,000 | -68.4% | 15,689 | -74.7% | 0.00% | – |
| Q4 2019 | $545,000 | +220.6% | 62,042 | +172.9% | 0.00% | – |
| Q3 2019 | $170,000 | -29.5% | 22,737 | -12.4% | 0.00% | – |
| Q2 2019 | $241,000 | +221.3% | 25,968 | +80.7% | 0.00% | – |
| Q1 2019 | $75,000 | -68.4% | 14,374 | -73.1% | 0.00% | – |
| Q4 2018 | $237,000 | -55.9% | 53,342 | -19.7% | 0.00% | – |
| Q3 2018 | $537,000 | +1.9% | 66,399 | -11.6% | 0.00% | – |
| Q2 2018 | $527,000 | +125.2% | 75,115 | +357.8% | 0.00% | – |
| Q1 2018 | $234,000 | -54.6% | 16,409 | -72.1% | 0.00% | – |
| Q4 2017 | $515,000 | +45.9% | 58,747 | +121.7% | 0.00% | – |
| Q1 2016 | $353,000 | – | 26,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |